Wednesday, 26 August 2026European Markets

LAVIDE HOLDING Shares Plunge 12% As Trading Day Draws To A Close

Loading stream...

(VIANEWS) - LaVide Holding (LVIDE.AS) shares fell 12.28% to EUR0.20 at 15:07 EST Wednesday after rising in previous sessions, although the AEX-Index showed improvement by rising 0.21% despite four consecutive losing sessions; this indicates a positive trading session thus far for LaVide Holding; its last closing price was EUR0.23, 55.299% below its 52-week high of EUR0.51.

About LAVIDE HOLDING

Lavide Holding N.V. was an established Dutch company which provided integrated information technology solutions to medium to large-sized companies and organizations, initially under its previous name of Qurius N.V. This business later changed to Lavide Holding N.V. after its rebrand in July 2013 from Sluis. Established in 1998 and with headquarters located there, Lavide Holding N.V. began operations on January 3, 1998 and remains operational today.

Yearly Analysis

Based on available information, LAVIDE HOLDING's stock is currently trading at EUR0.20 - significantly below its 52-week high of EUR0.51 but higher than its 52-week low of EUR0.14. This suggests that its prices have fluctuated considerably during its one-year existence - offering investors the chance to either purchase it at lower than anticipated levels or sell at higher than anticipated values. However, it is essential to remember that past performance does not guarantee future outcomes and investors should conduct their own analysis and due diligence before making investment decisions. When assessing potential growth and profitability of stocks it may be useful to take into account factors like financials, industry trends and market conditions as part of the evaluation process.

Technical Analysis

LAVIDE HOLDING's current stock price is significantly below both its 50-day and 200-day moving averages, signalling a downward trend in its value. This should serve as a warning sign to investors looking to sell or avoid LAVIDE HOLDING shares, with volume significantly lower than usual indicating lack of interest and trust in LAVIDE HOLDING shares. This also constitutes another bearish indicator. In recent periods, the stock's volatility has been relatively low: with average intraday variations of 1.22% over the past week and month and an amplitude of average volatility that reached its highest amplitude at 2.40% over time periods 3 to 4, suggesting short term stability but more significant fluctuations down the road. Overall, investors should exercise extreme caution when investing in LAVIDE HOLDING at its current price, given its bearish trend and likely significant fluctuations. Therefore, it may be prudent to wait for more favorable prices before considering investing.

Equity Analysis

Based on available information, LAVIDE HOLDING has reported an EPS figure of EUR-0.04, meaning they experienced a loss of EUR0.04 per share over the past year. A negative EPS suggests that they may not be producing profits for shareholders at present. Investors should examine this EPS figure alongside other financial metrics, such as revenue growth and expense control, in order to gain a full picture of LAVIDE HOLDING's financial health. Furthermore, it may be advantageous for them to compare LAVIDE HOLDING's EPS against that of its industry peers for greater insight into how well LAVIDE HOLDING performs relative to them.

More news about LAVIDE HOLDING (LVIDE.AS).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com